GE HealthCare's Portrait Mobile Gets FDA Nod for Wireless Patient Monitoring

GE HealthCare’s smart phone-sized Portrait Mobile frees the patient from the hospital bed while providing continuous monitoring of vital signs, usi...

August 15, 2023 | Tuesday | News
Pfizer's ELREXFIO™ Granted U.S. FDA Accelerated Approval for Refractory Multiple Myeloma

The approval of ELREXFIO (elranatamab-bcmm) is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study EL...

August 15, 2023 | Tuesday | News
Zetagen Raises $9.79M Series B for ZetaMet™ and ZetaMAST™ in Metastatic Lesion Treatment

ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently i...

August 14, 2023 | Monday | News
Longeveron Exceeds 50% Enrollment in Lomecel-B™ Study for Hypoplastic Left Heart Syndrome

Company Activates Additional Study Location to Expedite Enrollment Completion HLHS is a congenital birth defect in which the left ventricle (one of the pu...

August 14, 2023 | Monday | News
Imperative Care Unveils New Structure to Elevate Care for Patients with Vascular Diseases

-Imperative Care, Inc., a medical technology company elevating care for people affected by stroke and other ischemic diseases,  announced a new organi...

August 11, 2023 | Friday | News
United Digestive Announces Artificial Intelligence System for Enhanced Colonoscopy Screenings

United Digestive now offers patients receiving a colonoscopy an enhanced screening by GI Genius™ intelligent endoscopy module. The GI Geniu...

August 09, 2023 | Wednesday | News
Molecular Targeting Technologies and Singapore's Theranostics Center Gain HSA Approval for EBTATE® Trial in Nasopharyngeal Cancer

Somatostatin receptor 2 (SSTR2) is found in 81% of primary, recurrent, and metastatic NPC patients. EBTATE, the first patented and only long-acting peptide...

August 03, 2023 | Thursday | News
Clover Assistant Significantly Improves Early Chronic Kidney Disease Identification & Management

Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic K...

August 02, 2023 | Wednesday | News
Melinta Therapeutics Announces Commercial Availability of REZZAYO™ (rezafungin for injection)

Melinta Therapeutics, LLC  announced the availability of REZZAYO™ (rezafungin for injection), for the treatment of candidemia and invasive candi...

August 01, 2023 | Tuesday | News
FDA Streamlines Innovation for Opioid Use Disorder Devices

"The FDA continues to seek new ways to advance science to address the public health challenges that families and communities across the country face," said...

July 28, 2023 | Friday | News
Lenacapavir Shows Sustained Impact on HIV Patients' Quality of Life

Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...

July 26, 2023 | Wednesday | News
FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform

The FDA clearance also includes the company's core technology platform, the proprietary AXINON® System, that incorporates diagnostic testing algor...

July 26, 2023 | Wednesday | News
Lupin Emphasizes In-Home Cardiovascular Care with Digital Therapeutics

India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...

July 25, 2023 | Tuesday | News
AstraZeneca's Dapagliflozin Receives Expanded Approval for Heart Failure Treatment in India

AstraZeneca Pharma India has received extended indication approval from the Drugs Controller General of India (DCGI) for its drug, Dapagliflozin in the tre...

July 25, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close